For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Sherwood, M; Piccini, JP

Published Date

  • October 2012

Published In

Volume / Issue

  • 17 / 5

Start / End Page

  • 148 - 149

PubMed ID

  • 22345038

Pubmed Central ID

  • 22345038

Electronic International Standard Serial Number (EISSN)

  • 1473-6810

Digital Object Identifier (DOI)

  • 10.1136/ebmed-2011-100343

Language

  • eng

Conference Location

  • England